Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Crossover Trial of Pressure Targeted High Flow Therapy in Premature Infants

NCT07418502 is registered in ClinicalTrials.gov with University of Texas at Austin as lead sponsor.

NCT NCT07418502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07418502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Crossover Trial of Pressure Targeted High Flow Therapy in Premature Infants
Lead sponsor
University of Texas at Austin
Phase
Phase 2
Overall status
Not yet recruiting
Start date
May 1, 2026
Completion date
September 30, 2027
Enrollment
78 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bpd - bronchopulmonary dysplasia, preterm infants, respiratory distress syndrome (neonatal)